Therapeutic Potential of Mesenchymal Stem Cell–Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm‐Associated Diseases
International Journal of Microbiology · 2026-01 · 2026 (1)
DOI: 10.1155/ijm/4040189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Microbiology, online erschienen am 09.11.2026. Verfasst von Mohamad Arif und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Biomedical Science Faculty of Medicine Universitas Islam Sultan Agung Semarang Indonesia unissula.ac.id. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Incomplete bacterial eradication despite appropriate antimicrobial therapy contributes to the progression of some bacterial infections toward chronic or recurrent disease. Beyond genetically encoded antimicrobial resistance, bacterial persistence may be sustained by phenotypically tolerant subpopulations, including persister cells, together with biofilm‐associated growth. These states arise within heterogeneous microenvironments shaped by antimicrobial exposure, immune pressure, nutrient and oxygen limitation, and tissue injury. Failure of inflammation to resolve effectively may further promote persistent inflammatory signaling, impaired phagocytic function, localized hypoxia, and extracellular matrix disruption, thereby creating conditions that favor bacterial survival and biofilm stability. This review critically examines the mesenchymal stem cell–derived secretome as a potential host‐directed adjunct for persistent and biofilm‐associated bacterial infections. Rather than reiterating its antimicrobial, immunomodulatory, and regenerative properties, we integrate direct antibiofilm and antimicrobial evidence with indirect host‐mediated mechanisms involving NF‐ κ B modulation, proresolving macrophage responses, efferocytosis, and tissue repair. These actions may converge on host–pathogen niches that sustain bacterial persistence. However, direct evidence that MSC‐secretome reduces persister frequency, reverses bacterial dormancy, or eliminates persister populations remains limited. By distinguishing experimentally demonstrated effects from mechanistically inferred actions, this review proposes a host–pathogen ecological framework for evaluating MSC‐secretome in bacterial persistence. Current evidence remains predominantly preclinical. Key priorities include improved product standardization and potency assessment, validation in physiologically relevant chronic infection models, and clearer definition of dosing, delivery, and combination strategies with conventional antimicrobials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral Program in Biomedical Science Faculty of Medicine Universitas Islam Sultan Agung Semarang Indonesia unissula.ac.id.
- Department of Internal Medicine Faculty of Medicine Universitas Islam Sultan Agung Semarang Indonesia unissula.ac.id.
- Stem Cell and Cancer Research (SCCR) Semarang Indonesia.
- Lecturer Biomedical Science Undergraduate Program Agung Putra University (APU) Semarang Indonesia.
- Department of Paediatrics Faculty of Medicine Universitas Islam Sultan Agung Semarang Indonesia unissula.ac.id.
ORCID-Profile: Mohamad Arif, Agung Putra, Setyo Trisnadi, Sri Priyantini Mulyani
Zitieren
APA
Arif, M., Putra, A., Trisnadi, S., & Mulyani, S. P. (2026). Therapeutic Potential of Mesenchymal Stem Cell–Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm‐Associated Diseases. International Journal of Microbiology, 2026(1). https://doi.org/10.1155/ijm/4040189
Vancouver
Arif M, Putra A, Trisnadi S, Mulyani SP. Therapeutic Potential of Mesenchymal Stem Cell–Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm‐Associated Diseases. International Journal of Microbiology. 2026;2026(1). doi:10.1155/ijm/4040189
BibTeX
@article{Arif2026,
author = {Arif, Mohamad and Putra, Agung and Trisnadi, Setyo and Mulyani, Sri Priyantini},
title = {Therapeutic Potential of Mesenchymal Stem Cell–Derived Secretome in Bacterial Infections: Bridging Acute Inflammation and Biofilm‐Associated Diseases},
journal = {International Journal of Microbiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijm/4040189}
}
EUVIMED